申请人:DIEBOLD Robert Bruce
公开号:US20120035134A1
公开(公告)日:2012-02-09
The present invention relates to compounds of Formula (I):
and to their salts, pharmaceutical compositions, methods of use, and methods for their preparation. These compounds inhibit Bcl-2 and/or Bcl-X
L
activities and may be used for the treatment of cancer.
本发明涉及式(I)的化合物及其盐、药物组合物、使用方法和制备方法。这些化合物抑制Bcl-2和/或Bcl-XL活性,可用于癌症的治疗。